All patients deserve access to the right testing & treatment at the right time

From Testing to Targeted Treatment Program (FT3) is a non-profit multi-stakeholder collaborative program that aims to unify, accelerate and build on existing efforts to make precision medicine a reality for all patients who could benefit from it. Co-led by patients, FT3 is strongly focused on patient needs and experiences.

Discover the Story of Precision Medicine

A resource for all stakeholders in the Precision Medicine space to learn more about Precision Medicine, what it is, its history and application in real-life, including patient experiences and stories.

Find out more

Program highlights

The Story of Precision Medicine

A resource for all stakeholders in the Precision Medicine space to learn more about Precision Medicine, what it is, its history and application in real-life, including patient experiences and stories..

Find out more

Program update – June 2023

Here is an update on the latest developments and news in FT3. Please help us by sharing this update with your network, and thank you for your continued support in helping us make precision medicine a more accessible reality for patients!

Find out more

As the FT3 Country Pilots continue to advance, on behalf of the local steering groups I’m pleased to provide you with an update on the ongoing pilots in Spain and Hungary.

Read the full article here

From Testing to Targeted Treatments (FT3) Follow

A global collective program to make targeted medicine an accessible reality in oncology and beyond. #PrecisionMedicine #PersonalizedMedicine

Retweet on Twitter From Testing to Targeted Treatments (FT3) Retweeted

Avatar Razelle Kurzrock, MD @dr_r_kurzrock ·

10 Apr

FT3 Board meeting.

Just met him. Barry Stein!
Metastatic CRC (liver/ lungs) in 1995. Surgery & hepatic arterial infusion.

Amazing; it’s 2024 and he is here looking great & making a difference for others

👉Turning a diagnosis into hope for others.

Reply on Twitter 1778135638325260712 Retweet on Twitter 1778135638325260712 9 Like on Twitter 1778135638325260712 31 Twitter 1778135638325260712

Avatar From Testing to Targeted Treatments (FT3) @ft3program ·

4 Apr

"There is tremendous value in collecting #PatientExperienceData (PED), particularly in #precisionmedicine. It's still very challenging to gather that type of data. This however is essential!" - Barry Stein President & CEO @coloncanada, and FT3 Board Member #PEOF

Reply on Twitter 1775897499137634449 Retweet on Twitter 1775897499137634449 1 Like on Twitter 1775897499137634449 1 Twitter 1775897499137634449

About us

Our motivation

All patients deserve access to the right testing & treatment at the right time. While Precision Medicine (PM) can transform lives, its potential benefits have not yet been fully realized.

Our ambition

Our goal is to improve access to precision medicine for all patients who could benefit from it, by generating better evidence, creating awareness and building the conditions for better access, starting with testing and cancer.

Find out more

The partnership

We are an independent, nonprofit, global and multistakeholder consortium, building solutions with patients, for patients. Its members and community include individual patients, patient organizations, pharmaceutical & diagnostics companies, healthcare professionals and medical societies, payers, HTA bodies and regulators.

Find out more